Kyoto Prefectural University of Medicine is a public university in Kyoto, Kyoto, Japan. The school's predecessor was founded in 1872, and it was chartered as a university in 1921.

During the past decade, Kyoto Prefectural University of Medicine conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 7 clinical trials were completed, i.e. on average, 63.6% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 6 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kyoto Prefectural University of Medicine" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Kyoto Prefectural University of Medicine" with 4 trials sponsored, "Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan" with 3 trials sponsored, "AstraZeneca" with 2 trials sponsored and "BeiGene" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kyoto Prefectural University of Medicine" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator, "Tokyo Medical and Dental University" with 2 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Kurosawa Hospital" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Kyoto Prefectural University of Medicine" are "Atopic Dermatitis" (3 trials), "Acute Myocardial Infarction" (2 trials), "Colorectal Cancer" (2 trials), "Hypertension" (2 trials) and "Sarcoma" (2 trials). Many other conditions were trialed in "Kyoto Prefectural University of Medicine" in a lesser frequency.

Most popular intervention types in "Kyoto Prefectural University of Medicine" are "Drug" (19 trials), "Biological" (3 trials), "Radiation" (3 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Baricitinib" (2 trials), "UFT adjuvant chemotherapy" (2 trials), "cisplatin" (2 trials) and "cyclophosphamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Kyoto Prefectural University of Medicine" are 21 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Kyoto Prefectural University of Medicine". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Kyoto Prefectural University of Medicine, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Kyoto Prefectural University of Medicine, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".

Kyoto Prefectural University of Medicine has several departments that took part in Clinical trials: "Yoshimasa Diabetes & Endocrine Clinic" - 2 trials